Inhibiting Lipogenesis: This is the process where your body creates new fat
Pre-Blend Dose Assessment (10 units / 0.10 mL daily) Component GHK-Cu Per-dose from Blend ~1.67 mg Typical Standalone 1-2 mg daily Assessment In range Component BPC-157 Per-dose from Blend ~0.33 mg Typical Standalone 0.25-0.5 mg daily Assessment In range Component TB-500 Per-dose from Blend ~0.33 mg Typical Standalone 2-5 mg per injection, 2x/week Assessment Below standalone injury range The 5:1:1 blend is convenience- and skin-focused
Results showed 87.5% (14 of 16) experienced pain relief, with 91.6% responding to BPC-157 alone without additional treatments
This HO-1-dependent cytoprotective mechanism may explain much of BPC-157s observed ability to protect cells against ischaemia-reperfusion injury and oxidative damage across multiple tissue types simultaneously
While rare, its possible to have an allergic reaction, which could result in hives, swelling, or difficulty breathing
Human clinical evidence There are only two categories of human dataand neither supports its use in arthritis